Arun Mathew

Arun Mathew is a highly experienced professional in the pharmaceutical and healthcare industries, currently serving as Senior Medical Director at both Calcilytix Therapeutics and BridgeBio since July 2021. Prior to these roles, Arun held the position of Senior Medical Science Liaison at Ultragenyx Pharmaceutical Inc., contributing to the establishment of key relationships with opinion leaders and managing clinical data presentations related to rare genetic and metabolic bone diseases. With a background that includes roles in medical affairs, regulatory affairs, and pharmaceutical marketing, Arun possesses extensive expertise in clinical trial support, medical writing, and KOL engagement across various therapeutic areas. Academic credentials include multiple advanced degrees in public health, business administration, and pharmacy, complemented by diverse experiences ranging from adjunct professor to pharmacy extern.